 · FluorAbody® Engine · 
Our sequence‑defined, intrinsically fluorescent and recombinant antibody fragments are designed to bring consistency and traceability to modern R&D workflows. The Sequence-to-FluorAbody engine converts any validated antibody sequence into a fluorescent, single‑construct scFv - eliminating chemical conjugation variability and enabling reliable performance across assays, instruments, and production runs without the repeated re‑optimization caused by lot‑to‑lot discrepancies.
The engine supports a broad and expanding target portfolio and is built for applications in imaging, high‑throughput screening, quantitative immunoassays, live‑cell analysis, and flow cytometry. Each reagent is produced with a defined sequence representing true monoclonality and a genetically encoded fluorescence, ensuring consistent 1:1 labeling, stable performance, and reproducible data across experiments, users, and sites.

 · Fluorescent Tools · 
Our split fluorescent protein technologies facilitate R&D workflows, protein discovery, and protein expression optimization. These include Fold‑N‑Glow and Cut‑N‑Glow, each designed to simplify fluorescence‑based assays and accelerate experimental readouts.

 · GPER · 
We also offer agonists and antagonists for the G-protein estrogen receptor (GPER) signaling pathway, supporting research into estrogen-mediated signaling and cellular response mechanisms.

 · Collaborations · 
We collaborate with academic groups, biotech partners, and pharmaceutical R&D teams to advance reproducible science and next‑generation fluorescent reagent standards.


Sandia Biotech

Org chart

Teams

Offices

Sandia Biotech

Org chart

Teams

Offices

Related companies